A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

NCT04752774 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity

Interventions

BIOLOGICAL: IPN10200
DRUG: Placebo
BIOLOGICAL: Dysport

Sponsor

Ipsen